Skip to main content

Advertisement

Log in

Transurethral hot water balloon thermotherapy for benign prostatic hyperplasia

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

For many years the transurethral prostatectomy has been the standard therapy for benign prostatic hyperplasia (BPH). In the past 10 to 15 years, a number of competing minimally invasive technologies (MIT) have been used to treat patients with symptomatic BPH. These heat-based treatments include transurethral microwave thermotherapy, interstitial devices (eg, interstitial laser coagulation and transurethral needle ablation), high-intensity focused ultrasound, and water-induced thermotherapy (WIT). This article reviews the evidence supporting the efficacy and safety of transurethral hot water balloon thermotherapy for BPH. Appropriate patient selection factors for WIT versus other MITs are reviewed. A novel combination therapy for adenocarcinoma of the prostate also is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Lu-Yao GL, Barry MJ, Chang CH, et al.: Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). Urology 1994, 44:692–698.

    Article  PubMed  CAS  Google Scholar 

  2. Laguna MP, Muschter R, Debruyne FMJ: Microwave thermotherapy: historical overview. J Endourol 2000, 14:603–609.

    PubMed  CAS  Google Scholar 

  3. Edwards LE: History of non-surgical treatment. In Benign Prostatic Hypertrophy. Edited by Hinman F Jr. New York: Springer-Verlag; 1983:30.

    Google Scholar 

  4. Yerushalmi A, Fishelovitz Y, Singer D, et al.: Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985, 133:873–876.

    PubMed  CAS  Google Scholar 

  5. Hollingsworth E: Dilatation of the prostatic urethra for the relief of the symptoms of prostatic enlargement. Ann Surg 1910, 51:597–599.

    Google Scholar 

  6. Castaneda F, Isorna S, Hulbert JC, et al.: The importance of separation of prostatic lobes in relief of prostatic obstruction by balloon catheter urethroplasty: studies in dogs and humans. AJR 1989, 153:1301–1304.

    PubMed  CAS  Google Scholar 

  7. Lepor H, Sypherd D, Machi G, Derus J: Randomized doubleblind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1992, 147:639–644.

    PubMed  CAS  Google Scholar 

  8. Donatucci CF, Berger N, Kreder KJ, et al.: Randomized clinical trial comparing balloon dilatation to transurethral resection of prostate for benign prostatic hyperplasia. Urology 1993, 42:42–49.

    Article  PubMed  CAS  Google Scholar 

  9. Corica FA, Cheng L, Ramnani D, et al.: Transurethral hotwater balloon thermoablation for benign prostatic hyperplasia: patient tolerance and pathologic findings. Urology 2000, 56:76–80. This is the first clinical study to use WIT and show pathologic evidence of tissue effect on BPH.

    Article  PubMed  CAS  Google Scholar 

  10. Siegel YI, Zaidel L, Hammel I, et al.: Histopathology of benign prostatic hyperplasia after failure of hyperthermia treatment. Br J Urol 1991, 68:383–386.

    PubMed  CAS  Google Scholar 

  11. Larson TR, Collins JM: An accurate technique for detailed prostatic interstitial temperature-mapping in patients receiving microwave thermal treatment. J Endourol 1995, 9:339–347.

    Article  PubMed  CAS  Google Scholar 

  12. Muschter R, Schorsch I, Danielli L, et al.: Transurethral waterinduced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol 2000; 164:1565–1569. The first and only prospective, multicenter clinical trial for WIT and BPH.

    Article  PubMed  CAS  Google Scholar 

  13. ArgoMed Incorporated: Clinical results. http://www.argomed.com/physician/wit/clinical.html. Accessed January 14, 2003.

  14. Breda G, Isgro A: Treatment of benign prostatic hyperplasia with water-induced thermotherapy: experience of a single institution. J Endourol 2002, 16:123–126. A single-institution experience with WIT and patients in urinary retention.

    Article  PubMed  Google Scholar 

  15. McConnell JD, Barry MJ, Bruskewitz RC, et al.: Benign prostatic hyperplasia: diagnosis and treatment. Clinical practice guideline, Number 8; Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services, Rockville, MD AHCPR Publication No. 94-0582.(February 1994)

  16. Leibovich BC, Blute ML, Bostwick DG, et al.: Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology 2000, 56:726–729. A large pathologic study for prostate cancer showing urethral proximity for prostate cancer and recurrence rates.

    Article  PubMed  CAS  Google Scholar 

  17. Larson TR: Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology 2002, 59:12–16. An evidence-based review of the minimally invasive treatment choices for BPH.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mynderse, L.A., Larson, T.R. Transurethral hot water balloon thermotherapy for benign prostatic hyperplasia. Curr Urol Rep 4, 287–291 (2003). https://doi.org/10.1007/s11934-003-0086-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-003-0086-z

Keywords

Navigation